These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1830299)

  • 1. Tissue distribution of the C3d/EBV-receptor: CD21 monoclonal antibodies reactive with a variety of epithelial cells, medullary thymocytes, and peripheral T-cells.
    Timens W; Boes A; Vos H; Poppema S
    Histochemistry; 1991; 95(6):605-11. PubMed ID: 1830299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a human epithelial cell surface protein sharing an epitope with the C3d/Epstein-Barr virus receptor molecule of B lymphocytes.
    Young LS; Dawson CW; Brown KW; Rickinson AB
    Int J Cancer; 1989 May; 43(5):786-94. PubMed ID: 2469656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of the complement (CD21)/Epstein-Barr virus receptor in human lacrimal gland and ocular surface epithelia.
    Levine J; Pflugfelder SC; Yen M; Crouse CA; Atherton SS
    Reg Immunol; 1990-1991; 3(4):164-70. PubMed ID: 1966579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells.
    Carel JC; Frazier B; Ley TJ; Holers VM
    J Immunol; 1989 Aug; 143(3):923-30. PubMed ID: 2473114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2).
    Nemerow GR; Wolfert R; McNaughton ME; Cooper NR
    J Virol; 1985 Aug; 55(2):347-51. PubMed ID: 2410629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes.
    Fischer E; Delibrias C; Kazatchkine MD
    J Immunol; 1991 Feb; 146(3):865-9. PubMed ID: 1703182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies.
    Tsoukas CD; Lambris JD
    Eur J Immunol; 1988 Aug; 18(8):1299-302. PubMed ID: 2970972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection.
    Carel JC; Myones BL; Frazier B; Holers VM
    J Biol Chem; 1990 Jul; 265(21):12293-9. PubMed ID: 1695627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.
    Iida K; Nadler L; Nussenzweig V
    J Exp Med; 1983 Oct; 158(4):1021-33. PubMed ID: 6225820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle control of a Burkitt lymphoma cell line: responsiveness to growth signals engaging the C3D/EBV receptor.
    Pernegger G; Schulz TF; Hosp M; Myones BL; Petzer AL; Eigentler A; Böck G; Wick G; Dierich MP
    Immunology; 1988 Oct; 65(2):237-41. PubMed ID: 2461345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable expression and function of EBV/C3d receptor following genomic transfection into murine fibroblast L cells.
    Cantaloube JF; Piechaczyk M; Calender A; Lenoir G; Minty A; Carrière D; Fischer E; Poncelet P
    Eur J Immunol; 1990 Feb; 20(2):409-16. PubMed ID: 1690137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between Epstein-Barr virus and a T cell line (HSB-2) via a receptor phenotypically distinct from complement receptor type 2.
    Hedrick JA; Watry D; Speiser C; O'Donnell P; Lambris JD; Tsoukas CD
    Eur J Immunol; 1992 May; 22(5):1123-31. PubMed ID: 1315687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein Barr virus/complement C3d receptor is an interferon alpha receptor.
    Delcayre AX; Salas F; Mathur S; Kovats K; Lotz M; Lernhardt W
    EMBO J; 1991 Apr; 10(4):919-26. PubMed ID: 1849076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope mapping using the X-ray crystallographic structure of complement receptor type 2 (CR2)/CD21: identification of a highly inhibitory monoclonal antibody that directly recognizes the CR2-C3d interface.
    Guthridge JM; Young K; Gipson MG; Sarrias MR; Szakonyi G; Chen XS; Malaspina A; Donoghue E; James JA; Lambris JD; Moir SA; Perkins SJ; Holers VM
    J Immunol; 2001 Nov; 167(10):5758-66. PubMed ID: 11698449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD21 antigen in T-lineage neoplastic lymphoid cells: characteristic expression at thymic stage.
    Tatsumi E; Yoneda N; Kawano S; Yamaguchi N
    Am J Hematol; 1994 Feb; 45(2):150-5. PubMed ID: 7511331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of an Epstein-Barr virus receptor on human epithelial cells.
    Birkenbach M; Tong X; Bradbury LE; Tedder TF; Kieff E
    J Exp Med; 1992 Nov; 176(5):1405-14. PubMed ID: 1383386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional analysis of CR2/EBV receptor by means of monoclonal antibodies and limited tryptic digestion.
    Petzer AL; Schulz TF; Stauder R; Eigentler A; Myones BL; Dierich MP
    Immunology; 1988 Jan; 63(1):47-53. PubMed ID: 2448232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and antigenic analysis of the Epstein Barr virus/C3d receptor (CR2).
    Siaw MF; Nemerow GR; Cooper NR
    J Immunol; 1986 Jun; 136(11):4146-51. PubMed ID: 3009616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD21 is developmentally regulated during thymic maturation of human T lymphocytes.
    Fischer EM; Mouhoub A; Maillet F; Frémeaux-Bacchi V; Krief C; Gould H; Berrih-Aknin S; Kazatchkine MD
    Int Immunol; 1999 Nov; 11(11):1841-9. PubMed ID: 10545488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.
    Hutt-Fletcher LM; Fowler E; Lambris JD; Feighny RJ; Simmons JG; Ross GD
    J Immunol; 1983 Mar; 130(3):1309-12. PubMed ID: 6218205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.